Stacy Selke Selected Research

Herpes Genitalis (Genital Herpes)

12/2020	Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
1/2019	The Effect of Hormonal Contraception and Menstrual Cycle Timing on Genital Herpes Simplex Virus-2 Shedding and Lesions.
11/2018	Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.
10/2018	Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
12/2015	Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.
12/2015	High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.
1/2014	Helicase-primase inhibitor pritelivir for HSV-2 infection.
9/2006	Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
8/2005	Poor correlation between genital lesions and detection of herpes simplex virus in women in labor.
10/2004	Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stacy Selke Research Topics

Disease

17	Infections 01/2022 - 10/2002
12	Herpes Genitalis (Genital Herpes) 12/2020 - 10/2002
4	COVID-19 01/2022 - 10/2020
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Reinfection 01/2021 - 10/2020
2	Herpes Simplex 12/2017 - 11/2011
2	Viremia 09/2013 - 01/2009
1	Neonatal herpes 03/2022
1	Central Nervous System Diseases (CNS Diseases) 03/2022
1	Persistent Infection 12/2020
1	Gonorrhea 01/2020
1	Dysbiosis 01/2020
1	Herpesviridae Infections (Herpesvirus Infection) 11/2018
1	Latent Infection 01/2017
1	Congenital Abnormalities (Deformity) 01/2017
1	Virus Diseases (Viral Diseases) 02/2016
1	Erythema 09/2014
1	Human Influenza (Influenza) 09/2013
1	Malaria 09/2013
1	Acute malaria 09/2013
1	Inflammation (Inflammations) 06/2013
1	Headache (Headaches) 02/2012
1	Adenoviridae Infections (Adenovirus Infections) 06/2010
1	HIV Infections (HIV Infection) 01/2009
1	Diarrhea 07/2008
1	Central Nervous System Infections (Central Nervous System Infection) 07/2005

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 08/2004
5	Acyclovir (Aciclovir)FDA LinkGeneric 03/2022 - 03/2003
4	Neutralizing AntibodiesIBA 01/2022 - 10/2020
4	AntibodiesIBA 03/2021 - 10/2002
4	Antiviral Agents (Antivirals)IBA 10/2018 - 07/2005
4	Valacyclovir (Valtrex)FDA LinkGeneric 12/2016 - 10/2004
3	AntigensIBA 01/2022 - 09/2013
3	NucleoproteinsIBA 03/2021 - 10/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 03/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 10/2020
2	SARS-CoV-2 spike proteinIBA 01/2021 - 10/2020
2	VaccinesIBA 01/2017 - 09/2013
2	pritelivirIBA 12/2016 - 01/2014
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2011 - 08/2005
1	Nucleic AcidsIBA 01/2020
1	EnzymesIBA 12/2017
1	NucleosidesIBA 12/2016
1	Biological ProductsIBA 02/2016
1	Tenofovir (Viread)FDA Link 12/2015
1	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 12/2015
1	GlobinsIBA 12/2015
1	resiquimodIBA 09/2014
1	DNA Primase (Primase)IBA 01/2014
1	Amodiaquine (Camoquin)FDA Link 09/2013
1	Antimalarials (Antimalarial Agents)IBA 09/2013
1	ArtesunateIBA 09/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2013
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 09/2013
1	AIDS VaccinesIBA 06/2010
1	insulin receptor-related receptor (IRR)IBA 01/2009
1	Pharmaceutical PreparationsIBA 07/2008
1	Valganciclovir FDA Link 07/2008
1	Famciclovir (Famvir)FDA LinkGeneric 09/2006

Therapy/Procedure

6	Therapeutics 01/2021 - 09/2006
2	Transplantation 01/2022 - 01/2021
2	Donor Selection 01/2021 - 10/2020
2	Art Therapy 12/2020 - 11/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Hormonal Contraception 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 08/2004